---
title: "Palmitoyl Tripeptide-5"
canonical_url: https://peptidelibrary.app/library/palmitoyl-tripeptide-5
description: "Lipidated tripeptide marketed under the Syn-Coll name and used topically in firming and anti-ageing formulations. It is described as a thrombospondin-1 mimetic, intended to promote activation of transforming growth factor beta already present in the dermis rather than to supply new growth factor. Evidence comes predominantly from supplier research and small cosmetic studies. A cosmetic active, not a drug, and not FDA-approved."
updated: 2026-11-07
publisher: Peptide Library
notice: "Research and educational use only. Not medical advice."
---

# Palmitoyl Tripeptide-5

Palmitoyl Tripeptide-5 (also called Pal-KVK or Syn-Coll) is a cosmetic TGF-β mimetic tripeptide in the Matrix / Angiogenic class. Palmitoyl tripeptide-5 is a lipidated tripeptide used topically for effects on dermal collagen.

Lipidated tripeptide marketed under the Syn-Coll name and used topically in firming and anti-ageing formulations. It is described as a thrombospondin-1 mimetic, intended to promote activation of transforming growth factor beta already present in the dermis rather than to supply new growth factor. Evidence comes predominantly from supplier research and small cosmetic studies. A cosmetic active, not a drug, and not FDA-approved.

Also known as: Pal-KVK, Syn-Coll.

Categories: Cosmetic, Experimental.

## Classification

- Type: Cosmetic TGF-β mimetic tripeptide
- Mechanism class: Matrix / Angiogenic
- Development stage: Research only
- Regulatory class: Research compound, not FDA-approved

## Mechanism

Palmitoyl tripeptide-5 is a lipidated tripeptide used topically for effects on dermal collagen. It is described as a mimetic of thrombospondin-1, the endogenous activator of latent transforming growth factor beta, and the proposed mechanism is that it promotes conversion of latent TGF-beta already present in the dermis into its active form rather than supplying new growth factor. Active TGF-beta drives fibroblast collagen synthesis. The evidence is predominantly supplier research and small cosmetic studies; independent controlled trials of the isolated peptide have not been published, and topical penetration remains the general constraint for peptides of this size.

Targets: TGF-β pathway (claimed), Collagen I.

Origin: Synthetic palmitoylated tripeptide.

## Properties

- Molecular formula: C33H65N5O5
- CAS number: 623172-55-4
- Half-life: Topical; systemic PK not established

## Evidence

- Evidence level: Insufficient Evidence
- Highest documented: Early or uncontrolled human studies
- Human trials: 1
- Controlled human trials: 0
- Preclinical sources: 0
- Latest source: 2021

No human dose is established for this compound.

Each step shows whether the sources Peptide Library has reviewed include that kind of research. Counts are reviewed sources, not every study ever published. Reviews and programme summaries that describe human use are shown as "reported", not as trials, and registered trials without published results are listed but not counted. A higher step means research has progressed further; it does not mean a compound works better or is safer. Compounds whose evidence has not been reviewed yet show "Not reviewed" instead of a guess.

### Studies

1. Avcil M et al. Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study. J Cosmet Dermatol. 2020. 2020. Human study (early or uncontrolled). Population: Healthy adults with aged skin (number not stated in the indexed abstract). Fine lines and wrinkles 25.8% lower, hydration 15.4% higher, dermal density and thickness 14.2% and 12.9% higher; no skin reactions [Source](https://pubmed.ncbi.nlm.nih.gov/31134751/)
2. Resende DISP et al. Usage of Synthetic Peptides in Cosmetics for Sensitive Skin. Pharmaceuticals (Basel). 2021. 2021. Secondary report (review or programme summary), not a trial. Population: 88 facial products for sensitive skin from multinational brands (a product survey, not a study of people). Palmitoyl tripeptide-5 was one of seven peptides found; the authors note that the supporting data are mostly in patents and supplier brochures, not randomised placebo-controlled studies. Limitations: Reported in research, not a controlled trial. [Source](https://pubmed.ncbi.nlm.nih.gov/34451799/)

## Safety

Side effects: Irritation.

Risks: Cosmetic only.

Human safety basis: No controlled human safety data

Key limitations: No established human dosage.; No controlled human trial results in the reviewed sources.; Not approved by the FDA for any use..

## Regulatory status

Palmitoyl Tripeptide-5 is not an FDA-approved product. It is sold for laboratory research and has no approved medical use.

- FDA status: Not Approved
- WADA status: Permitted
- Availability: OTC / Supplement

## Frequently asked questions

### What is Palmitoyl Tripeptide-5?

Lipidated tripeptide marketed under the Syn-Coll name and used topically in firming and anti-ageing formulations. It is described as a thrombospondin-1 mimetic, intended to promote activation of transforming growth factor beta already present in the dermis rather than to supply new growth factor. Evidence comes predominantly from supplier research and small cosmetic studies. A cosmetic active, not a drug, and not FDA-approved.

### How does Palmitoyl Tripeptide-5 work?

Palmitoyl tripeptide-5 is a lipidated tripeptide used topically for effects on dermal collagen. It is described as a mimetic of thrombospondin-1, the endogenous activator of latent transforming growth factor beta, and the proposed mechanism is that it promotes conversion of latent TGF-beta already present in the dermis into its active form rather than supplying new growth factor.

### Is Palmitoyl Tripeptide-5 FDA approved?

No. Palmitoyl Tripeptide-5 is not approved by the FDA for any indication and is categorised as otc / supplement. It has not been reviewed for safety or efficacy as a medicine, and published research should be read as investigation rather than established use.

### What is the half-life of Palmitoyl Tripeptide-5?

Reported half-life for Palmitoyl Tripeptide-5 is Topical; systemic PK not established. Half-life describes how long the compound persists in circulation, not how long any effect lasts, and published figures vary with route of administration, formulation and the population studied.

### Is Palmitoyl Tripeptide-5 banned in sport?

Palmitoyl Tripeptide-5 is recorded here as permitted in sport. Anti-doping status is revised annually, so athletes subject to testing should confirm against the current WADA Prohibited List before use.

### What peptides are similar to Palmitoyl Tripeptide-5?

Compounds most often compared with Palmitoyl Tripeptide-5 include Palmitoyl Pentapeptide-4, Palmitoyl Tetrapeptide-7, Acetyl Hexapeptide-8 and Acetyl Octapeptide-3. They are grouped by shared mechanism or research area rather than by equivalence, and their regulatory status and evidence base differ.

## References

- [PubChem Pal-KVK](https://pubchem.ncbi.nlm.nih.gov/compound/Palmitoyl%20tripeptide-5)
- [Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study — J Cosmet Dermatol, 2020](https://pubmed.ncbi.nlm.nih.gov/31134751/)
- [Usage of Synthetic Peptides in Cosmetics for Sensitive Skin — Pharmaceuticals (Basel), 2021](https://pubmed.ncbi.nlm.nih.gov/34451799/)
- [Lipidated peptide nanostructures for stabilizing hydrogels with sustained skincare bioactivity — J Control Release, 2026](https://pubmed.ncbi.nlm.nih.gov/41344485/)
- [Supramolecular collagen nanoparticles for anti-wrinkle, skin whitening, and moisturizing effects — Colloids Surf B Biointerfaces, 2025](https://pubmed.ncbi.nlm.nih.gov/39383579/)
- [Delivery of Active Peptides by Self-Healing, Biocompatible and Supramolecular Hydrogels — Molecules, 2023](https://pubmed.ncbi.nlm.nih.gov/36985499/)
